Editorial: Vector-based gene delivery in cancer immunotherapy.
作者信息
Cheng Ning, Yang Xiaoyue, Chen Dan, Xu Chun
机构信息
State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan University, Wuhan, China.
Department of Biochemical and Cellular Pharmacology, Genentech, Inc, South San Francisco, CA, United States.
出版信息
Front Immunol. 2025 Mar 18;16:1587359. doi: 10.3389/fimmu.2025.1587359. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Vector-based gene delivery in cancer immunotherapy.社论：癌症免疫治疗中基于载体的基因递送
Front Immunol. 2025 Mar 18;16:1587359. doi: 10.3389/fimmu.2025.1587359. eCollection 2025.
2
Cancer gene therapy goes viral: viral vector platforms come of age.癌症基因治疗迎来病毒载体时代：病毒载体平台渐趋成熟。
Radiol Oncol. 2022 Feb 11;56(1):1-13. doi: 10.2478/raon-2022-0002.
3
Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.日本血凝病毒在治疗性递送系统中的应用。
Expert Opin Drug Deliv. 2008 Feb;5(2):221-33. doi: 10.1517/17425247.5.2.221.
4
Non-viral gene delivery for cancer immunotherapy.非病毒基因传递在癌症免疫治疗中的应用。
J Gene Med. 2019 Jul;21(7):e3092. doi: 10.1002/jgm.3092. Epub 2019 May 28.
5
The role of cytokines in shaping the future of Cancer immunotherapy.细胞因子在塑造癌症免疫治疗未来中的作用。
Cytokine. 2025 May;189:156888. doi: 10.1016/j.cyto.2025.156888. Epub 2025 Feb 25.
6
Combined delivery of a TGF-β inhibitor and an adenoviral vector expressing interleukin-12 potentiates cancer immunotherapy.联合递送 TGF-β 抑制剂和表达白细胞介素-12 的腺病毒载体增强癌症免疫治疗。
Acta Biomater. 2017 Oct 1;61:114-123. doi: 10.1016/j.actbio.2017.05.009. Epub 2017 May 5.
7
Non-viral vector-based genome editing for cancer immunotherapy.基于非病毒载体的癌症免疫治疗基因组编辑。
Biomater Sci. 2024 Jun 11;12(12):3068-3085. doi: 10.1039/d4bm00286e.
8
Replicating viral vector platform exploits alarmin signals for potent CD8 T cell-mediated tumour immunotherapy.复制病毒载体平台利用警报素信号进行有效的 CD8 T 细胞介导的肿瘤免疫治疗。
Nat Commun. 2017 May 26;8:15327. doi: 10.1038/ncomms15327.
9
Recent development of gene therapy for pancreatic cancer using non-viral nanovectors.近年来，非病毒纳米载体在胰腺癌基因治疗中的应用进展。
Biomater Sci. 2021 Oct 12;9(20):6673-6690. doi: 10.1039/d1bm00748c.
10
A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy.一种多功能非病毒载体，用于递送 MTH1 靶向的 CRISPR/Cas9 系统，用于非小细胞肺癌治疗。
Acta Biomater. 2022 Nov;153:481-493. doi: 10.1016/j.actbio.2022.09.046. Epub 2022 Sep 24.
本文引用的文献
1
Gene Therapy Cargoes Based on Viral Vector Delivery.基于病毒载体递送的基因治疗载体。
Curr Gene Ther. 2023;23(2):111-134. doi: 10.2174/1566523222666220921112753.
2
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL.非病毒、特异性靶向 CAR-T 细胞在 B-NHL 中具有高安全性和疗效。
Nature. 2022 Sep;609(7926):369-374. doi: 10.1038/s41586-022-05140-y. Epub 2022 Aug 31.
3
Cancer gene therapy goes viral: viral vector platforms come of age.癌症基因治疗迎来病毒载体时代：病毒载体平台渐趋成熟。
Radiol Oncol. 2022 Feb 11;56(1):1-13. doi: 10.2478/raon-2022-0002.
4
Tumour vasculature: Friend or foe of oncolytic viruses?肿瘤血管：溶瘤病毒的朋友还是敌人？
Cytokine Growth Factor Rev. 2020 Dec;56:69-82. doi: 10.1016/j.cytogfr.2020.07.007. Epub 2020 Sep 1.
5
The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers.溶瘤痘病毒 JX-594 选择性地在由常见于癌症中的遗传途径驱动的癌细胞中复制并破坏这些癌细胞。
Mol Ther. 2012 Apr;20(4):749-58. doi: 10.1038/mt.2011.276. Epub 2011 Dec 20.
Zotero 插件